Clopidogrel (I): Bagel brunch: Fatal forty DDI: Clopidogrel, omeprazole, CYP2C19

Ann Marie Canelas, Randal O. Dull

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This case discusses the interaction between clopidogrel and omeprazole. Clopidogrel is a prodrug metabolized to an intermediate compound by cytochrome P450 2C19. Omeprazole is a 2C19 inhibitor.

Original languageEnglish (US)
Title of host publicationA Case Approach to Perioperative Drug-Drug Interactions
PublisherSpringer New York
Pages681-684
Number of pages4
ISBN (Electronic)9781461474951
ISBN (Print)9781461474944
DOIs
StatePublished - Sep 15 2015
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Clopidogrel (I): Bagel brunch: Fatal forty DDI: Clopidogrel, omeprazole, CYP2C19'. Together they form a unique fingerprint.

  • Cite this

    Canelas, A. M., & Dull, R. O. (2015). Clopidogrel (I): Bagel brunch: Fatal forty DDI: Clopidogrel, omeprazole, CYP2C19. In A Case Approach to Perioperative Drug-Drug Interactions (pp. 681-684). Springer New York. https://doi.org/10.1007/978-1-4614-7495-1_151